Jingyi Hu

Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy

Yang Xiao, Lingxiang Xie, Zhiguang Zhou, 2022, Frontiers in Endocrinology.

Decreased serum fibroblast growth factor 19 level is a risk factor for type 1 diabetes

Xia Li, Zhiguang Zhou, Gan Huang, 2021, Annals of translational medicine.

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications

Yang Xiao, Lingxiang Xie, Zhiguang Zhou, 2022, Frontiers in Immunology.

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma

Lingxiang Xie, Yi Chu, Z. Mei, 2022, Frontiers in Immunology.

Associations between Diabetes and Idiopathic Pulmonary Fibrosis: A Study-level Pooled analysis of 26 Million People.

Zhiguang Zhou, Zhuo-wei Hu, Ji-Hao Yan, 2021, The Journal of clinical endocrinology and metabolism.

Fibroblast Growth Factor 19 Levels Predict Subclinical Atherosclerosis in Men With Type 2 Diabetes

A. Xu, Zhiguang Zhou, P. Zhou, 2020, Frontiers in Endocrinology.

Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization study

Jiawen Lu, Zhenqiang Wang, Jingyi Hu, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Distinct signatures of gut microbiota and metabolites in different types of diabetes: a population-based cross-sectional study

Jun Yu Li, Xia Li, Tingting Zheng, 2023, EClinicalMedicine.

Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes

Zhiguang Zhou, C. Chao, Yang Xiao, 2021, Chinese medical journal.